Responses
Immunotherapy biomarkers
Original research
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis
Compose a Response to This Article
Other responses
No responses have been published for this article.